National Beverage Returns to Top-Line Growth, But Margin and Equity Erosion Raise Caution

What happened

National Beverage reported Q1 fiscal 2027 revenue of $330.7 million, its first year-over-year growth since Q1 2026, ending a prolonged period of volume-driven declines. However, the revenue rebound came at a cost: gross margin fell to 35% from historical levels around 37-38%, and EPS declined from $0.60 to $0.50, indicating that the growth may be driven by lower pricing or increased promotions rather than volume recovery. The company also paid a $3.25 per share special dividend, which sharply reduced shareholder equity and underscores management's preference for returning cash rather than reinvesting, even as the core LaCroix franchise faces intense competition from Coca-Cola, PepsiCo, and private label. The prior thesis of a 'WAIT' strategy was based on volume declines and a premium valuation; the new results suggest that while revenue has stabilized, profitability is deteriorating, and the balance sheet is being intentionally shrunk. This combination of lower margins, shrinking equity, and competitive pressures raises the bar for any upgrade to a buy, as the stock still trades above a conservative intrinsic value estimate.

Implication

The revenue growth is a positive signal that demand may be stabilizing for LaCroix and other brands, but the decline in gross margin to 35% suggests that the company is sacrificing profitability to generate sales, which is not sustainable unless volume growth follows. The drop in EPS from $0.60 to $0.50 indicates that even with higher revenues, bottom-line profitability is declining, which could pressure the stock's valuation multiple if the trend continues. The special dividend of $3.25 per share, while returning cash to shareholders, reduces book value and may signal that management sees limited high-return reinvestment opportunities, which is a concern for long-term growth. Given the intense competition from larger beverage companies and the company's narrow moat, the path to restoring both volume growth and margins simultaneously remains uncertain, and the stock's current valuation does not offer a sufficient margin of safety. Therefore, investors should wait for evidence that the revenue rebound is driven by volume improvement rather than price cuts, and that gross margin can return to historical levels, before considering a more positive stance.

Thesis delta

The prior thesis was WAIT due to volume declines and premium valuation. The new data shows revenue growth but lower margins and EPS, and a special dividend that reduces equity. The shift is negative: while top line stabilizes, the quality of earnings is deteriorating, and capital allocation is reducing the balance sheet cushion, moving the stance to a more cautious watch.